Is low dose hydroxyurea the solution to the global epidemic of sickle cell disease?

Pediatr Blood Cancer. 2015 Jun;62(6):929-30. doi: 10.1002/pbc.25471. Epub 2015 Mar 8.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anemia, Sickle Cell / drug therapy*
  • Anemia, Sickle Cell / epidemiology
  • Child
  • Humans
  • Hydroxyurea / adverse effects
  • Hydroxyurea / therapeutic use*

Substances

  • Hydroxyurea